| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Jalota Deepika | Chief Development Officer | C/O PMV PHARMACEUTICALS, INC., ONE RESEARCH WAY, PRINCETON | /s/ Robert Ticktin, by power of attorney | 03 Jul 2025 | 0001825192 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | PMVP | Common Stock | Sale | $35,198 | -33,065 | -27% | $1.06 | 89,959 | 01 Jul 2025 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units, or RSUs. |